DEUTSCHE BANK AG\ - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,593,280
+26.4%
91,726
+2.5%
0.00%0.0%
Q2 2023$1,260,245
+18.8%
89,506
-9.2%
0.00%0.0%
Q1 2023$1,060,667
-5.9%
98,575
+31.0%
0.00%0.0%
Q4 2022$1,127,380
+15.0%
75,259
-1.4%
0.00%0.0%
Q3 2022$980,000
+32.6%
76,312
+0.1%
0.00%
Q2 2022$739,000
-4.3%
76,228
-1.8%
0.00%
Q1 2022$772,000
-18.4%
77,658
-3.4%
0.00%
Q4 2021$946,000
+5.0%
80,367
+1.6%
0.00%
Q3 2021$901,000
-18.8%
79,112
-0.7%
0.00%
-100.0%
Q2 2021$1,109,000
-48.2%
79,655
-31.1%
0.00%0.0%
Q1 2021$2,140,000
+390.8%
115,635
+368.1%
0.00%
Q4 2020$436,000
+87.1%
24,704
+62.0%
0.00%
Q3 2020$233,000
-9.3%
15,252
+50.8%
0.00%
Q2 2020$257,000
+256.9%
10,116
+115.6%
0.00%
Q1 2020$72,000
+33.3%
4,691
-5.7%
0.00%
Q4 2019$54,000
+74.2%
4,973
+29.1%
0.00%
Q3 2019$31,000
-75.6%
3,852
-59.7%
0.00%
Q2 2019$127,000
-48.4%
9,559
-30.6%
0.00%
Q1 2019$246,000
+26.2%
13,764
+97.2%
0.00%
Q4 2018$195,000
-72.3%
6,981
-74.8%
0.00%
Q3 2018$704,00027,6830.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,474,561$42,983,1255.17%
Rubric Capital Management LP 3,077,449$53,455,2892.00%
Parkman Healthcare Partners LLC 509,810$8,855,4001.62%
TANG CAPITAL MANAGEMENT LLC 600,000$10,422,0001.47%
AlphaCentric Advisors LLC 110,000$1,910,7001.08%
Lion Point Capital, LP 130,691$2,270,1031.01%
RICE HALL JAMES & ASSOCIATES, LLC 650,366$11,296,8570.72%
ESSEX INVESTMENT MANAGEMENT CO LLC 185,853$3,228,2670.53%
ADVISORY RESEARCH INC 204,098$3,545,1820.49%
Jackson Creek Investment Advisors LLC 65,607$1,1400.48%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders